PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites

Council Directive (EC) 2007/47/EC of the 5th September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market

Council Directive (EC) 93/42/EEC of 14 June 1993 concerning medical devices

Council Directive (EC) 98/79/EC of 27 October 1998 on in vitro diagnostic medical devices

Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006 Mar; 42(5): 589–97

Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007 May; 18(5): 945–9

Wilailak S, Linasmita V, Srivannaboon S. Malignant ascites in female patients: a seven-year review. J Med Assoc Thai 1999 Jan; 82(1): 15–9

Adam RA, Adam YG. Malignant ascites: past, present, and future. J Am Coll Surg 2004 Jun; 198(6): 999–1011

Keen A, Fitzgerald D, Bryant A, et al. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev 2010; (1): CD007794

Hanks G, Cherny NI, Christakis NA, et al. Oxford textbook of palliative medicine. 4th ed. New York: Oxford University Press, 2010

Lee CW, Bociek G, Faught W. A survey of practice in management of malignant ascites. J Pain Symptom Manage 1998 Aug; 16(2): 96–101

White J, Carolan-Rees G, Dale M. External Assessment Centre report: PleurX indwelling peritoneal catheter for vacuum assisted drainage of recurrent malignant ascites at home. Cardiff: Cedar, 2011 Sep 16

Jacob A, Hassan H, Puro P, et al. Long-term tunnelled PleurX peritoneal catheters in the management of recurrent malignant ascites: inital experience and cost effectiveness [poster]. Society of Gastrointestinal Intervention Third Annual Meeting; 2009 Oct 9–10; Seoul

Mullan D, Laasch H-U, Jacob AHH. Tunneled intra-peritoneal catheters in the management of malignant ascites: complications and cost implications [2012]. Unpublished

Mullan D, Laasch H-U, Hassan H. Fibrinolysis in the management of malignant ascites and non-functioning intra-peritoneal tunnelled catheters [2011]. Unpublished

Brooks RA, Herzog TJ, Brooks RA, et al. Long-term semipermanent catheter use for the palliation of malignant ascites. Gynecol Oncol 2006 May; 101(2): 360–2

Courtney A, Nemcek Jr AA, Rosenberg S, et al. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol 2008 Dec; 19(12): 1723–31

Iyengar TD, Herzog TJ, Iyengar TD, et al. Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hospice Palliat Med 2002 Jan; 19(1): 35–8

Richard III HMC. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 2001; 12(3): 373–5

Rosenberg S, Courtney A, Nemcek Jr AA, et al. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol 2004; 15(10): 1129–31

Saiz-Mendiguren R, Gomez-Ayechu M, Noguera JJ, et al. Permanent tunneled drainage for malignant ascites: initial experience with the PleurX catheter. [in Spanish]. Radiologia (Panama) 2010; 52(6): 541–5

Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol 2012 May; 85(1013): 623–8

Day R, Keen A, Perkins P. What are the experiences of patients with malignant abdominal ascites? [poster]. 12th Congress of the European Association for Palliative Care; 2011 May 18–21; Lisbon

Curtis L, editor. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 2010

National Institute for Health and Clinical Excellence. The PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment resistent, recurrent malignant ascites. Consultation Document, 2011 Nov [online]. Available from URL: http://guidance.nice.org.uk/MT/131/Consultation/DraftGuidance [Accessed 2012 Jun 7]

National Institute for Health and Clinical Excellence. Medical Technology Guidance 9: 2012 March [online]. Available from URL: http://guidance.nice.org.uk/MTG9/Guidance/pdf/English [Accessed 2012 Jun 7]

Drummond MF, Griffin A, Tarricone R. Economic evaluation for devices and drugs: same or different? Value Health 2009; 12(4): 402–4